$MOH
MOLINA HEALTHCARE, INC. Stock $moh

$moh Overview Financials Valuation SEC Filings Company Website

2013 Q1 Form 10-Q Financial Statement

#000144530513001088 Filed on May 03, 2013

Income Statement

Concept	2013 Q1	2012 Q4	2012 Q1
Revenue	$1.590B	$1.578B	$1.374B
YoY Change	15.78%	20.79%	22.67%
Cost Of Revenue	$1.328B	$1.319B	$1.108B
YoY Change	19.79%	22.46%	17.32%
Gross Profit	$262.7M	$259.1M	$208.6M
YoY Change	25.93%	12.9%	19.2%
Gross Profit Margin	16.52%	16.42%	15.19%
Selling, General & Admin	$178.3M	$191.1M	$157.4M
YoY Change	13.28%	13.14%	20.15%
% of Gross Profit	67.87%	73.76%	75.46%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$21.80M	$20.50M	$18.34M
YoY Change	18.87%	-6.82%	1.32%
% of Gross Profit	8.3%	7.91%	8.79%
Operating Expenses	$194.8M	$207.3M	$172.2M
YoY Change	13.12%	14.53%	19.92%
Operating Profit	$67.87M	$54.13M	$33.42M
YoY Change	103.09%	-436.17%	6.77%
Interest Expense	$13.04M	-$4.300M	$4.298M
YoY Change	203.33%	10.26%	-219.39%
% of Operating Profit	19.21%	-7.94%	12.86%
Other Income/Expense, Net	-$12.91M	$300.0K	-$4.298M
YoY Change	200.28%
Pretax Income	$54.97M	$50.15M	$29.12M
YoY Change	88.75%	-351.28%	5.14%
Income Tax	$24.45M	$21.60M	$11.03M
% Of Pretax Income	44.47%	43.07%	37.89%
Net Earnings	$29.92M	$25.64M	$18.09M
YoY Change	65.38%	-177.8%	4.03%
Net Earnings / Revenue	1.88%	1.63%	1.32%
Basic Earnings Per Share	$0.65	$0.55	$0.39
Diluted Earnings Per Share	$0.64	$0.54	$0.39
COMMON SHARES
Basic Shares Outstanding	45.98M shares	46.58M shares	46.00M shares
Diluted Shares Outstanding	46.44M shares		46.89M shares

Balance Sheet

Concept	2013 Q1	2012 Q4	2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.512B	$1.139B	$875.7M
YoY Change	72.6%	37.07%	9.28%
Cash & Equivalents	$1.170B	$796.0M	$517.7M
Short-Term Investments	$341.9M	$342.8M	$358.0M
Other Short-Term Assets	$39.58M	$28.39M	$38.70M
YoY Change	2.27%	46.06%	-12.05%
Inventory
Prepaid Expenses
Receivables	$150.3M	$149.7M	$222.3M
Other Receivables	$0.00	$0.00	$15.30M
Total Short-Term Assets	$1.727B	$1.349B	$1.152B
YoY Change	49.92%	28.72%	13.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$237.7M	$221.4M	$198.6M
YoY Change	19.71%	15.98%	84.23%
Goodwill	$151.1M	$151.1M
YoY Change		-1.86%
Intangibles
YoY Change
Long-Term Investments	$13.60M	$13.40M	$16.10M
YoY Change	-15.53%	243.59%	-20.3%
Other Assets	$29.45M	$19.62M	$126.1M
YoY Change	-76.65%	14.75%	20.32%
Total Long-Term Assets	$761.1M	$585.7M	$588.0M
YoY Change	29.43%	-3.04%	3.61%
TOTAL ASSETS
Total Short-Term Assets	$1.727B	$1.349B	$1.152B
Total Long-Term Assets	$761.1M	$585.7M	$588.0M
Total Assets	$2.488B	$1.935B	$1.740B
YoY Change	42.99%	17.11%	9.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$160.0M	$184.0M	$124.6M
YoY Change	28.41%	25.0%	9.59%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.167M	$1.155M	$1.100M
YoY Change	6.09%	-3.51%
Total Short-Term Liabilities	$803.0M	$828.0M	$677.1M
YoY Change	18.6%	37.59%	9.9%
LONG-TERM LIABILITIES
Long-Term Debt	$642.0M	$261.8M	$228.2M
YoY Change	181.33%	20.68%	37.97%
Other Long-Term Liabilities	$23.84M	$23.48M	$22.20M
YoY Change	7.38%	7.8%	-49.2%
Total Long-Term Liabilities	$665.8M	$285.3M	$250.4M
YoY Change	165.91%	19.5%	19.75%
TOTAL LIABILITIES
Total Short-Term Liabilities	$803.0M	$828.0M	$677.1M
Total Long-Term Liabilities	$665.8M	$285.3M	$250.4M
Total Liabilities	$1.724B	$1.153B	$964.7M
YoY Change	78.7%	28.47%	14.49%
SHAREHOLDERS EQUITY
Retained Earnings	$530.1M	$500.2M
YoY Change		2.0%
Common Stock	$234.2M	$285.5M
YoY Change		7.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$0.00	$3.000M
YoY Change
Treasury Stock Shares	0.000 shares	111.0K shares
Shareholders Equity	$764.2M	$782.3M	$775.3M
YoY Change
Total Liabilities & Shareholders Equity	$2.488B	$1.935B	$1.740B
YoY Change	42.99%	17.11%	9.9%

Cashflow Statement

Concept	2013 Q1	2012 Q4	2012 Q1
OPERATING ACTIVITIES
Net Income	$29.92M	$25.64M	$18.09M
YoY Change	65.38%	-177.8%	4.03%
Depreciation, Depletion And Amortization	$21.80M	$20.50M	$18.34M
YoY Change	18.87%	-6.82%	1.32%
Cash From Operating Activities	$20.10M	$83.80M	$50.58M
YoY Change	-60.25%	19.37%	-39.86%
INVESTING ACTIVITIES
Capital Expenditures	-$11.20M	-$25.60M	-$13.50M
YoY Change	-17.04%	74.15%	-9.4%
Acquisitions	$0.00
YoY Change
Other Investing Activities	-$10.00M	$22.80M	-$29.20M
YoY Change	-65.75%	-122.89%	-54.94%
Cash From Investing Activities	-$21.20M	-$2.800M	-$42.72M
YoY Change	-50.37%	-97.55%	-46.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$50.00M		$0.00
YoY Change
Debt Paid & Issued, Net	$291.0K		$301.0K
YoY Change	-3.32%
Cash From Financing Activities	$374.8M	-700.0K	$16.04M
YoY Change	2237.03%	-101.39%	358.26%
NET CHANGE
Cash From Operating Activities	$20.10M	83.80M	$50.58M
Cash From Investing Activities	-$21.20M	-2.800M	-$42.72M
Cash From Financing Activities	$374.8M	-700.0K	$16.04M
Net Change In Cash	$373.7M	80.30M	$23.90M
YoY Change	1464.03%	1154.69%	206.36%
FREE CASH FLOW
Cash From Operating Activities	$20.10M	$83.80M	$50.58M
Capital Expenditures	-$11.20M	-$25.60M	-$13.50M
Free Cash Flow	$31.30M	$109.4M	$64.08M
YoY Change	-51.14%	28.86%	-35.28%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	159986000	USD
CY2012Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	184034000	USD
CY2013Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	14944000	USD
CY2012Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6520000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-197000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-457000	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	285524000	USD
CY2013Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	234236000	USD
CY2012Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4666000	USD
CY2013Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4421000	USD
CY2012Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1443000	USD
CY2013Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3723000	USD
CY2012Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	258000	USD
CY2013Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1248000	USD
CY2012Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	549700000	USD
CY2013Q1	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	572900000	USD
CY2013Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	25500	shares
CY2012Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7900	shares
CY2012Q4	us-gaap	Assets Assets	1934822000	USD
CY2013Q1	us-gaap	Assets Assets	2488089000	USD
CY2013Q1	us-gaap	Assets Current AssetsCurrent	1727038000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	1349126000	USD
CY2013Q1	us-gaap	Auction Rate Securities Noncurrent AuctionRateSecuritiesNoncurrent	13600000	USD
CY2012Q4	us-gaap	Auction Rate Securities Noncurrent AuctionRateSecuritiesNoncurrent	13419000	USD
CY2012Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	357000000	USD
CY2013Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	355864000	USD
CY2008Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	82100000	USD
CY2012Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	89195000	USD
CY2013Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	73704000	USD
CY2012Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	13419000	USD
CY2013Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	13600000	USD
CY2013Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	167493000	USD
CY2013Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	167801000	USD
CY2013Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	14500000	USD
CY2013Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	13600000	USD
CY2013Q1	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	355864000	USD
CY2013Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	173871000	USD
CY2013Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	174145000	USD
CY2013Q1	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	355546000	USD
CY2012Q4	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	356264000	USD
CY2013Q1	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	355546000	USD
CY2012Q4	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	1545000	USD
CY2013Q1	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	1192000	USD
CY2012Q4	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses2 AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses2	1231000	USD
CY2013Q1	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses2 AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses2	900000	USD
CY2012Q4	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses2 AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses2	314000	USD
CY2013Q1	us-gaap	Availableforsale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses2 AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses2	292000	USD
CY2013Q1	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	874000	USD
CY2012Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	809000	USD
CY2013Q1	us-gaap	Availableforsale Securities Sold At Par AvailableforsaleSecuritiesSoldAtPar	67600000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1169511000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	795770000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	517723000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	493827000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	373741000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	23896000	USD
CY2013Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	53.8475
CY2013Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2013Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45415000	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46762000	shares
CY2012Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	47000	USD
CY2013Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	45000	USD
CY2012Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	18385000	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	30175000	USD
CY2012Q1	us-gaap	Costs And Expenses CostsAndExpenses	1340167000	USD
CY2013Q1	us-gaap	Costs And Expenses CostsAndExpenses	1523496000	USD
CY2012Q4	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	58313000	USD
CY2013Q1	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	53813000	USD
CY2013Q1	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	13490236	shares
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.39
CY2013Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	800000	USD
CY2013Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y10M18D
CY2012Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	3592000	USD
CY2013Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	1177000	USD
CY2013Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	42000	USD
CY2012Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	31000	USD
CY2013Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	579860000	USD
CY2013Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	737000000	USD
CY2013Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2013-02-15
CY2013Q1	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	157140000	USD
CY2013Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	135804000	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	141798000	USD
CY2013Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	25753000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	32443000	USD
CY2013Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	31353000	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	37900000	USD
CY2013Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	16565000	USD
CY2012Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	15025000	USD
CY2012Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18339000	USD
CY2013Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	21799000	USD
CY2013Q1	us-gaap	Derivative Assets DerivativeAssets	147385000	USD
CY2012Q4	us-gaap	Derivative Assets DerivativeAssets	0	USD
CY2012Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	0	USD
CY2013Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	119000	USD
CY2012Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1307000	USD
CY2013Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	223647000	USD
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.65
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.39
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.64
CY2012Q1	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	30942000	USD
CY2013Q1	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	77711000	USD
CY2012Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	44543000	USD
CY2013Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-5994000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	72864000	USD
CY2013Q1	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	0	USD
CY2012Q1	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	1747000	USD
CY2012Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	121474000	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	141407000	USD
CY2013Q1	us-gaap	Goodwill Goodwill	151088000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	151088000	USD
CY2013Q1	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	1534608000	USD
CY2012Q1	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	1325406000	USD
CY2013Q1	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	3501000	USD
CY2013Q1	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount	3500000	USD
CY2013Q1	us-gaap	Held To Maturity Securities Debt Maturities Fair Value HeldToMaturitySecuritiesDebtMaturitiesFairValue	55123000	USD
CY2013Q1	us-gaap	Held To Maturity Securities Debt Maturities Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmount	55117000	USD
CY2013Q1	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	51622000	USD
CY2013Q1	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	51617000	USD
CY2012Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	29122000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	54185000	USD
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24270000	USD
CY2012Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11033000	USD
CY2013Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	14712000	USD
CY2012Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	1057000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-34796000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-31847000	USD
CY2013Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	8424000	USD
CY2012Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-3663000	USD
CY2012Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-8263000	USD
CY2013Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	16000	USD
CY2012Q1	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	53357000	USD
CY2013Q1	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	-3385000	USD
CY2012Q1	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	2457000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	408000	USD
CY2013Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	8956000	USD
CY2012Q4	us-gaap	Line Of Credit Facility Amount Outstanding LineOfCreditFacilityAmountOutstanding	40000000	USD
CY2013Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	170000000	USD
CY2013Q1	us-gaap	Liabilities Current LiabilitiesCurrent	803046000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	828037000	USD
CY2013Q1	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	491145000	USD
CY2012Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	494530000	USD
CY2012Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5640000	USD
CY2013Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	569000	USD
CY2012Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	54356000	USD
CY2012Q1	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	493000	USD
CY2013Q1	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	11016000	USD
CY2012Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	32000	shares
CY2013Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2012Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	857000	shares
CY2013Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	462000	shares
CY2013Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	1529000	USD
CY2012Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	1717000	USD
CY2013Q1	us-gaap	Interest Expense InterestExpense	13037000	USD
CY2012Q1	us-gaap	Interest Expense InterestExpense	4298000	USD
CY2012Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	3196000	USD
CY2013Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	6250000	USD
CY2012Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1753000	USD
CY2013Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	2527000	USD
CY2013Q1	us-gaap	Interest Paid InterestPaid	17065000	USD
CY2012Q1	us-gaap	Interest Paid InterestPaid	799000	USD
CY2013Q1	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	-1502000	USD
CY2012Q1	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	-1850000	USD
CY2012Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	10300000	USD
CY2013Q1	us-gaap	Liabilities Liabilities	1723890000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	1152508000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1934822000	USD
CY2013Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2488089000	USD
CY2012Q1	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	23527000	USD
CY2013Q1	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
CY2013Q1	us-gaap	Long Term Debt LongTermDebt	784179000	USD
CY2012Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1155000	USD
CY2013Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1167000	USD
CY2013Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	591170000	USD
CY2013Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	863000	USD
CY2013Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	1372000	USD
CY2013Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	1309000	USD
CY2013Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	1259000	USD
CY2013Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	188206000	USD
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	261784000	USD
CY2013Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	642005000	USD
CY2013Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	341946000	USD
CY2012Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	342845000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	16039000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	374837000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-42718000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21200000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	20104000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	50575000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	29915000	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	18089000	USD
CY2013Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	67091000	USD
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	33420000	USD
CY2012Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	4259000	USD
CY2013Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	4694000	USD
CY2013Q1	us-gaap	Other Assets Current OtherAssetsCurrent	39577000	USD
CY2012Q4	us-gaap	Other Assets Current OtherAssetsCurrent	28386000	USD
CY2013Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	29449000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	19621000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	260000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	296000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	100000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	300000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	296000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	260000	USD
CY2012Q1	us-gaap	Other Income OtherIncome	0	USD
CY2013Q1	us-gaap	Other Income OtherIncome	131000	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	23480000	USD
CY2013Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	23839000	USD
CY2012Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4298000	USD
CY2013Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-12906000	USD
CY2013Q1	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	16100000	USD
CY2012Q1	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	0	USD
CY2013Q1	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	149331000	USD
CY2013Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	50000000	USD
CY2012Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2012Q1	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	13505000	USD
CY2013Q1	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	11167000	USD
CY2013Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	76012000	USD
CY2012Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	88199000	USD
CY2012Q1	us-gaap	Payments To Acquire Projects PaymentsToAcquireProjects	12993000	USD
CY2013Q1	us-gaap	Payments To Acquire Projects PaymentsToAcquireProjects	-1756000	USD
CY2013Q1	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	1288754000	USD
CY2012Q1	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	1130988000	USD
CY2013Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q1	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	0	USD
CY2012Q1	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	9162000	USD
CY2012Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	537973000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	235000	USD
CY2012Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2748000	USD
CY2012Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	75074000	USD
CY2012Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	10000000	USD
CY2013Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2013Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	149300000	USD
CY2013Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	75647000	USD
CY2012Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	65767000	USD
CY2013Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	237735000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	221443000	USD
CY2013Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	94000	USD
CY2012Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	64000	USD
CY2013Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	150251000	USD
CY2012Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	149682000	USD
CY2013Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	40000000	USD
CY2013Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	291000	USD
CY2012Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	301000	USD
CY2012Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	USD
CY2013Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	40000000	USD
CY2013Q1	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	450500000	USD
CY2012Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	46900000	USD
CY2012Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	44101000	USD
CY2013Q1	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	55117000	USD
CY2013Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	530115000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	500200000	USD
CY2013Q1	us-gaap	Revenues Revenues	1590587000	USD
CY2012Q1	us-gaap	Revenues Revenues	1373587000	USD
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	300000	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	45000000	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	33.02
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	13.97
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3398000	USD
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	414061000	shares
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4421000	USD
CY2012Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4666000	USD
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	7750	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	22.93
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	601175	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	31.40
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	986577	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1170518	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	23.74
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	28.23
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	409484	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	22.16
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	390760000	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		USD
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	445760000	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	3398000	USD
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	445760000	shares
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	3398000	USD
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y9M18D
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P3Y9M18D
CY2012Q4	us-gaap	Shares Outstanding SharesOutstanding	46762000	shares
CY2011Q4	us-gaap	Shares Outstanding SharesOutstanding	45815000	shares
CY2013Q1	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	8600000	USD
CY2013Q1	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	585500000	USD
CY2013Q1	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	341700000	USD
CY2013Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	279000	shares
CY2013Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	13001000	shares
CY2013Q1	us-gaap	Stock Repurchase Program Authorized Amount StockRepurchaseProgramAuthorizedAmount	75000000	USD
CY2013Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	4644000	USD
CY2012Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	8768000	USD
CY2013Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1624959	shares
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	764199000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	782314000	USD
CY2013Q1	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	0.0375	USD
CY2013Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	0	USD
CY2012Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	1747000	USD
CY2012Q1	us-gaap	Technology Services Costs TechnologyServicesCosts	30494000	USD
CY2013Q1	us-gaap	Technology Services Costs TechnologyServicesCosts	39770000	USD
CY2012Q1	us-gaap	Technology Services Revenue TechnologyServicesRevenue	42205000	USD
CY2013Q1	us-gaap	Technology Services Revenue TechnologyServicesRevenue	49756000	USD
CY2013Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2012Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	111000	shares
CY2013Q1	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2012Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3000000	USD
CY2013Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10600000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10600000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	56000	USD
CY2013Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	60000	USD
CY2013Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	7200000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	7200000	USD
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46443000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46887000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	0	shares
CY2013Q1	moh	Current Year Components Of Incurred Medical Care Costs CurrentYearComponentsOfIncurredMedicalCareCosts	1347181000	USD
CY2012Q1	moh	Current Year Components Of Incurred Medical Care Costs CurrentYearComponentsOfIncurredMedicalCareCosts	1167580000	USD
CY2013Q1	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	867000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	86000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	183000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45998000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45981000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	202500	shares
CY2012Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	199700	shares
CY2012Q1	moh	Amount Of Current Year Quality Incentive Premium Revenue Recognized AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized	8764000	USD
CY2013Q1	moh	Amount Of Current Year Quality Incentive Premium Revenue Recognized AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized	14896000	USD
CY2013Q1	moh	Amount Of Quality Incentive Premium Revenue Recognized From Prior Year AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear	6712000	USD
CY2012Q1	moh	Amount Of Quality Incentive Premium Revenue Recognized From Prior Year AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear	994000	USD
CY2012Q4	moh	Anticipated Medicare Risk Adjustment Premiums AnticipatedMedicareRiskAdjustmentPremiums	300000	USD
CY2013Q1	moh	Anticipated Medicare Risk Adjustment Premiums AnticipatedMedicareRiskAdjustmentPremiums	200000	USD
CY2012Q4	moh	Available For Sale Securities In Unrealized Loss Position Less Than Twelve Months Qualitative Disclosure Number Of Positions AvailableForSaleSecuritiesInUnrealizedLossPositionLessThanTwelveMonthsQualitativeDisclosureNumberOfPositions	72	Security
CY2013Q1	moh	Available For Sale Securities In Unrealized Loss Position Less Than Twelve Months Qualitative Disclosure Number Of Positions AvailableForSaleSecuritiesInUnrealizedLossPositionLessThanTwelveMonthsQualitativeDisclosureNumberOfPositions	65	Security
CY2012Q4	moh	Available For Sale Securities In Unrealized Loss Position Twelve Months Or More Qualitative Disclosure Number Of Positions AvailableForSaleSecuritiesInUnrealizedLossPositionTwelveMonthsOrMoreQualitativeDisclosureNumberOfPositions	21	Security
CY2013Q1	moh	Available For Sale Securities In Unrealized Loss Position Twelve Months Or More Qualitative Disclosure Number Of Positions AvailableForSaleSecuritiesInUnrealizedLossPositionTwelveMonthsOrMoreQualitativeDisclosureNumberOfPositions	19	Security
CY2013Q1	moh	Benefit From Prior Period Claims Development BenefitFromPriorPeriodClaimsDevelopment	58400000	USD
CY2013Q1	moh	Call Spread Cash Paid CallSpreadCashPaid	74200000	USD
CY2013Q1	moh	Class Of Warrant Or Right Trading Days Measurement Period ClassOfWarrantOrRightTradingDaysMeasurementPeriod	P160D
CY2012Q1	moh	Current Year Payments For Medical Care Costs CurrentYearPaymentsForMedicalCareCosts	750994000	USD
CY2013Q1	moh	Current Year Payments For Medical Care Costs CurrentYearPaymentsForMedicalCareCosts	916426000	USD
CY2013Q1	moh	Denominator For Basic Earnings Per Share DenominatorForBasicEarningsPerShare	45981000	shares
CY2012Q1	moh	Denominator For Basic Earnings Per Share DenominatorForBasicEarningsPerShare	45998000	shares
CY2013Q1	moh	Denominator For Diluted Earnings Per Share DenominatorForDilutedEarningsPerShare	46443000	shares
CY2012Q1	moh	Denominator For Diluted Earnings Per Share DenominatorForDilutedEarningsPerShare	46887000	shares
CY2012Q4	moh	Goodwill And Intangible Assets Net GoodwillAndIntangibleAssetsNet	228799000	USD
CY2013Q1	moh	Goodwill And Intangible Assets Net GoodwillAndIntangibleAssetsNet	223952000	USD
CY2012Q4	moh	Health Plans Segment Receivables HealthPlansSegmentReceivables	127098000	USD
CY2013Q1	moh	Health Plans Segment Receivables HealthPlansSegmentReceivables	133742000	USD
CY2012Q1	moh	Prior Year Components Of Incurred Medical Care Costs PriorYearComponentsOfIncurredMedicalCareCosts	-36592000	USD
CY2012Q4	moh	Liability For Claims And Claims Adjustment Expense Health LiabilityForClaimsAndClaimsAdjustmentExpenseHealth	494530000	USD
CY2013Q1	moh	Liability For Claims And Claims Adjustment Expense Health LiabilityForClaimsAndClaimsAdjustmentExpenseHealth	491145000	USD
CY2012Q1	moh	Liability For Claims And Claims Adjustment Expense Health LiabilityForClaimsAndClaimsAdjustmentExpenseHealth	455833000	USD
CY2011Q4	moh	Liability For Claims And Claims Adjustment Expense Health LiabilityForClaimsAndClaimsAdjustmentExpenseHealth	402476000	USD
CY2012Q1	moh	Maximum Available Quality Incentive Premium Current Year MaximumAvailableQualityIncentivePremiumCurrentYear	9399000	USD
CY2013Q1	moh	Maximum Available Quality Incentive Premium Current Year MaximumAvailableQualityIncentivePremiumCurrentYear	20615000	USD
CY2013Q1	moh	Maximum Contract Term MaximumContractTerm	P4Y
CY2013Q1	moh	Minimum Contract Term MinimumContractTerm	P3Y
CY2013Q1	moh	Minimum Ebitda Percentage For Vesting Of Awards MinimumEbitdaPercentageForVestingOfAwards	0.025
CY2013Q1	moh	Minimum Operating Revenue For Vesting Of Awards MinimumOperatingRevenueForVestingOfAwards	12000000000	USD
CY2013Q1	moh	Number Of Categories For Component Of Premium Revenue NumberOfCategoriesForComponentOfPremiumRevenue	2
CY2013Q1	moh	Number Of Members Eligible For Health Care Programs NumberOfMembersEligibleForHealthCarePrograms	1800000	Customer
CY2013Q1	moh	Number Of Operating Reportable Segments NumberOfOperatingReportableSegments	2	Segment
CY2013Q1	moh	Par Value Of Auction Rate Securities Sold ParValueOfAuctionRateSecuritiesSold	14500000	USD
CY2012Q1	moh	Payments For Medical Care Costs PaymentsForMedicalCareCosts	1077631000	USD
CY2013Q1	moh	Payments For Medical Care Costs PaymentsForMedicalCareCosts	1292139000	USD
CY2012Q1	moh	Payments For Medical Services Fees To Related Party PaymentsForMedicalServicesFeesToRelatedParty	6600000	USD
CY2013Q1	moh	Payments For Medical Services Fees To Related Party PaymentsForMedicalServicesFeesToRelatedParty	7700000	USD
CY2012Q1	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.091
CY2013Q1	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.118
CY2012Q1	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.032
CY2013Q1	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.045
CY2013Q1	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.038
CY2012Q1	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.028
CY2013Q1	moh	Premium Tax Expenses PremiumTaxExpenses	37000000	USD
CY2012Q1	moh	Premium Tax Expenses PremiumTaxExpenses	42186000	USD
CY2013Q1	moh	Prior Year Components Of Incurred Medical Care Costs PriorYearComponentsOfIncurredMedicalCareCosts	-58427000	USD
CY2013Q1	moh	Prior Year Payments For Medical Care Costs PriorYearPaymentsForMedicalCareCosts	375713000	USD
CY2012Q1	moh	Prior Year Payments For Medical Care Costs PriorYearPaymentsForMedicalCareCosts	326637000	USD
CY2012Q1	moh	Quality Incentive Premium Revenue Recognized QualityIncentivePremiumRevenueRecognized	9758000	USD
CY2013Q1	moh	Quality Incentive Premium Revenue Recognized QualityIncentivePremiumRevenueRecognized	21608000	USD
CY2012Q1	moh	Retirement Of Treasury Stock RetirementOfTreasuryStock	0	USD
CY2013Q1	moh	Retirement Of Treasury Stock RetirementOfTreasuryStock	53000000	USD
CY2012Q4	moh	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingIntrinsicValue		USD
CY2013Q1	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue	22.23
CY2013Q1	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageGrantDateFairValue	17.97
CY2013Q1	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue	17.63
CY2013Q1	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodIntrinsicValue		USD
CY2013Q1	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue		USD
CY2013Q1	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageFairValue	23.60
CY2012Q4	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageFairValue	22.39
CY2013Q1	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue	23.60
CY2013Q1	moh	Stock Repurchase Program Average Price Per Share StockRepurchaseProgramAveragePricePerShare	30.77
CY2013Q1	moh	Unrecognized Tax Benefits State Refund Claims UnrecognizedTaxBenefitsStateRefundClaims	8400000	USD
CY2012Q4	moh	Unrecognized Tax Benefits State Refund Claims UnrecognizedTaxBenefitsStateRefundClaims	8400000	USD
CY2013Q1	moh	Unvested Share Based Compensation Recognition Period UnvestedShareBasedCompensationRecognitionPeriod	P2Y9M18D
CY2013Q1	dei	Amendment Flag AmendmentFlag	false
CY2013Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2013Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013Q1	dei	Document Period End Date DocumentPeriodEndDate	2013-03-31
CY2013Q1	dei	Document Type DocumentType	10-Q
CY2013Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001179929
CY2013Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	45416300	shares
CY2013Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2013Q1	dei	Entity Registrant Name EntityRegistrantName	MOLINA HEALTHCARE INC
CY2013Q1	dei	Trading Symbol TradingSymbol	moh

Files In Submission

Name	View Source	Status
0001445305-13-001088-index-headers.html	Edgar Link	pending
0001445305-13-001088-index.html	Edgar Link	pending
0001445305-13-001088.txt	Edgar Link	pending
0001445305-13-001088-xbrl.zip	Edgar Link	pending
ex101.gif	Edgar Link	pending
ex102.jpg	Edgar Link	pending
ex102a.jpg	Edgar Link	pending
ex103.gif	Edgar Link	pending
ex104.jpg	Edgar Link	pending
ex104a.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
moh-20130331.xml	Edgar Link	completed
moh-20130331.xsd	Edgar Link	pending
moh-20130331x10q.htm	Edgar Link	pending
moh-20130331_cal.xml	Edgar Link	unprocessable
moh-20130331_def.xml	Edgar Link	unprocessable
moh-20130331_lab.xml	Edgar Link	unprocessable
moh-20130331_pre.xml	Edgar Link	unprocessable
moh-2013x03x31xex101.htm	Edgar Link	pending
moh-2013x03x31xex102.htm	Edgar Link	pending
moh-2013x03x31xex104.htm	Edgar Link	pending
moh-2013x03x31xex311.htm	Edgar Link	pending
moh-2013x03x31xex312.htm	Edgar Link	pending
moh-2013x03x31xex321.htm	Edgar Link	pending
moh-2013x03x31xex322.htm	Edgar Link	pending
moh-2031x03x31xex103.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MOH
MOLINA HEALTHCARE, INC. Stock $moh

2013 Q1 Form 10-Q Financial Statement

#000144530513001088 Filed on May 03, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH MOLINA HEALTHCARE, INC. Stock $moh

2013 Q1 Form 10-Q Financial Statement

#000144530513001088 Filed on May 03, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH
MOLINA HEALTHCARE, INC. Stock $moh